# US 2020/0206390 A1 · Titanium Alloy For Medical Devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0206390 A1
- Document ID: US20200206390A1
- Status: Published application
- Kind: A1
- Application number: 16/695,809
- Filed: 2019-11-26
- Published: 2020-07-02
- Earliest claimed: 2018-12-26
- Assignees: MiRus LLC
- Applicants: MiRus LLC
- Inventors: Noah Roth
- Web page: https://patentgrep.com/patent/US20200206390A1

## CPC

- A61L 31/022: {Metals or alloys}
- A61L 27/06: Titanium or titanium alloys
- A61L 29/02: Inorganic materials
- C21D 8/0236: {Cold rolling}
- C21D 9/0068: {for particular articles not mentioned below}
- C22C 14/00: Alloys based on titanium
- C22F 1/183: {of titanium or alloys based thereon}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C21D: MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING (surface treatment of metallic material involving at least one process provided for in class C23 and at least one process covered by this subclass C23F17/00; unidirectional solidification of eutectic materials or unidirectional demixing of eutectoid materials C30B)
- C22C: ALLOYS (treatment of alloys C21D, C22F)
- C22F: CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS (surface treatment of metallic material involving at least one process provided for in class C23 and at least one process covered by this subclass, C23F17/00)

## Abstract

A medical device at least partially formed of a novel titanium alloy of at least about 90 wt. % of a solid solution of titanium and molybdenum.

## Claims

### Claim 1

A medical device at least partially formed of a metal alloy, said metal alloy includes at least about 90 wt. % of a solid solution of titanium, molybdenum, and optionally additional metal additive, said metal alloy includes at least 51 wt. % titanium, 0.1-40 wt. % molybdenum, and up to 5 wt. % of said additional metal additive.

### Claim 2 (depends on 1)

The medical device as defined in claim 1, wherein said metal alloy includes at 75-90 wt. % titanium.

### Claim 3 (depends on 1)

The medical device as defined in claim 1, wherein said metal alloy includes 10-25 wt. % molybdenum.

### Claim 4 (depends on 1)

The medical device as defined in claim 1, wherein said metal alloy includes 0.01-5 wt. % of said additional metal additive.

### Claim 5 (depends on 1)

The medical device as defined in claim 1, wherein said medical device is fully formed of said metal alloy.

### Claim 6 (depends on 1)

The medical device as defined in claim 1, wherein said additional metal additive includes rhenium, yttrium, niobium, cobalt, chromium, and/or zirconium.

### Claim 7 (depends on 1)

The medical device as defined in claim 1, wherein said metal alloy a) has a yield strength of 170-230 ksi, b) includes carbon and oxygen wherein a carbon to oxygen atomic ratio is at least about 2.5:1, c) has a carbon to nitrogen atomic ratio of less than about 40:1, d) has an oxygen to nitrogen atomic ratio of less than about 30:1, e) has an average grain size of ASTM 5 or ASTM 5+, f) has an elongation of at least 8%, and/or g) has a hardness in a range from 340-600 HV.

### Claim 8 (depends on 1)

The medical device as defined in claim 1, wherein said metal alloy includes about 75-90 wt. % titanium, about 25-10 wt. % molybdenum, and about 0.02-0.5 wt. % of said additional metal, said additional metal including a metal selected from the group consisting of rhenium, yttrium, niobium, cobalt, chromium, and zirconium.

### Claim 9 (depends on 1)

The medical device as defined in claim 1, wherein said metal alloy includes less than about 0.2 wt. % carbon, less than about 0.1 wt. % oxygen, and less than about 0.001 wt. % nitrogen.

### Claim 10

A method of manufacturing a medical device at least partially formed of a metal alloy having a cross sectional thickness of less than 15 mm comprising:
a. forming a member from a metal alloy that forms at least a portion of said medical device, said metal alloy formed by a hot or cold press process and has been optionally annealed and optionally aged, said member optionally having a cylindrical shape, said metal alloy including at least about 90 wt. % of a solid solution of titanium and molybdenum, said metal alloy optionally having a yield strength of 170-230 ksi, said metal alloy optionally including carbon and oxygen and having a carbon to oxygen atomic ratio of at least about 2.5:1; said metal alloy optionally having a carbon to nitrogen atomic ratio of less than about 40:1, said metal alloy optionally having an oxygen to nitrogen atomic ratio of less than about 30:1, said metal alloy optionally having an average grain size of at least 5 ASTM, said metal alloy optionally having an elongation of at least 8%, said metal alloy having a hardness of 340-600 HV.

### Claim 11 (depends on 10)

The method as defined in claim 10, further including the step of age treating said metal alloy, wherein said age treatment is performed at a temperature of 300-800° C.

### Claim 12 (depends on 10)

The method as defined in claim 10, further including the step of cold rolling said metal alloy to cause a 5-90% reduction in cross-sectional area of said metal alloy optionally without subjecting said metal alloy to a solution treatment.

### Claim 12 (depends on 10)

The method as defined in claim 10, further including the step of reducing said cross-sectional area of said metal alloy by 40-70% by a process in accordance with ASTM E8.

### Claim 13

A method of manufacturing a medical device at least partially formed of a metal alloy having a cross-sectional thickness of less than 15 mm comprising:
a. rod member of a titanium alloy, said rod member having an average cross-sectional thickness of greater than 15 mm, said titanium alloy including at least about 95 wt. % of a solid solution of titanium and molybdenum, said titanium alloy a) having a yield strength of at least 170 ksi, b) including carbon and oxygen wherein a oxygen atomic ratio is at least about 2.5:1, c) including carbon, oxygen, and nitrogen and having a carbon to nitrogen atomic ratio of less than about 40:1 and an oxygen to nitrogen atomic ratio of less than about 30:1, d) having an average grain size of over 5 ASTM, e) having an elongation of said member of at least 8%; and/or f) having a hardness of at least 340 Hv; and
b. forming said titanium alloy into at least a portion of said medical device and reducing said average cross-sectional thickness of said titanium alloy to less than 15 mm, wherein said titanium alloy is optionally age treated at a temperature of 300-800° C. for at least 10 minutes;
wherein said titanium alloy is optionally cold rolled to a 5-90% reduction without subjecting said titanium alloy to a solution treatment; and,
wherein said rod member is optionally reduced in cross-sectional thickness by at least 40% per ASTM E8.

### Claim 14 (depends on 13)

The method as defined in claim 13, wherein said titanium alloy includes about 75-90 wt. % titanium, about 25-10 wt. % molybdenum, and about 0.02-0.5 wt. % additional metal, said additional metal including rhenium, yttrium, niobium, cobalt, chromium, and/or zirconium.

### Claim 15 (depends on 13)

The method as defined in claim 13, further including the step of forming said titanium alloy into a cylindrical rod having a diameter of greater than 15 mm.

### Claim 16 (depends on 13)

The method as defined in claim 13, wherein said titanium alloy is a hot or cold press alloy that has been annealed and aged.

### Claim 17 (depends on 13)

The method as defined in claim 13, wherein said titanium alloy has a yield strength of 170-230 ksi.

### Claim 18 (depends on 13)

The method as defined in claim 13, wherein said rod member has a reduction in cross-sectional per ASTM E8 of 40-70%

### Claim 19 (depends on 13)

The method as defined in claim 13, wherein said titanium alloy includes about 75-90 wt. % titanium, about 25-10 wt. % molybdenum, and about 0.02-0.5 wt. % an additional metal, said additional metal including rhenium, yttrium, niobium, cobalt, chromium, and/or zirconium.
